note: details related to offering this course during Academic year 2020-2021 are under discussion and will be posted when available.

Designed as a model partnership between the educational and business communities, this five-day laboratory course offers participants the opportunity to continue their learning and skill development. Its intensive, integrated format combines lectures, hands-on lab exercises and interactive problem-solving sessions. Participants will benefit from the knowledge and expertise of highly qualified scientists-instructors and researchers who represent the worlds of both academia and the private sector. Tapping the talents of invited speakers, evening talks are designed to supplement daytime activities, stimulating dialogue regarding current issues in biotechnology.

Offered with generous support from Promega Corporation

BioPharmaceutical Technology Center Institute
Department of Oncology, UW-Madison
Research & Development and Technical Support Services, Promega Corporation

  • UW-Madison students and special students admitted to the course and wishing to receive 2 credits will enroll through the University registration system and will remit tuition fees directly to the University.
  • For students who do not wish to receive university credits, a special rate of $1600 is offered. (Documentation of current enrollment in an academic institution is required for confirmation of this special rate.)
  • For company employees, faculty and all others, the fee is $1800.
  • Eligibility: Graduate students, biotechnology and pharmaceutical industry employees, secondary and post-secondary teachers, with a B.S. in either biology or chemistry and a minimum of one advanced course in molecular biology. Course enrollment is limited to 20 participants.
  • Application:  Submit a registration form.
    If you wish to receive graduate credit through UW-Madison
    , please be sure to use the Comment section included in this form to detail your prior experiences using molecular biology and your learning goals for the week, as instructed on the form.
    If you do not wish to receive graduate credit through UW-Madison
    , please also share that information with us. Your enrollment in the course will be verified upon receipt of payment. Payment options are included in the registration form.
  • NOTE: UW-Madison Graduate Students wishing to receive credit: Please submit your registration form before May 15, 2020. We will review this document and let you know of your acceptance to the course.
  • Richard Burgess, Ph.D. (Professor, Department of Oncology, UW-Madison)
  • Amy Prevost, Ph.D. (Director, Scientific Courses, BTC Institute)
  • Review of transcription, translation and epigenetics
  • Transfection
  • Cytotoxicity:apoptosis, necrosis and autophagy
  • Molecular biology and drug discovery
  • Mass spectrometry
  • Bioinformatics
  • Reporter genes and vectors
  • Rapid affinity chromatography methods
  • Patent Law and Intellectual Property
  • Next Generation sequencing
  • Kinases inhibition for the development of pharmaceuticals
Laboratory Work:
  • Transfection and Analysis of Transfection Efficiency
  • Kinetic cytoxicity assays
  • Selective and pan assays of epigenetic enzymes
  • Analysis of kinase inhibition and drug discovery
  • Working with mass spectrometry data
  • Extensive discussion of data, data analysis and application of theories and techniques to the current work of course participants.